FYERS
Home
/
Stocks
/
Results
/
Kwality Pharmaceuticals Results

Kwality Pharmaceuticals Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
21%14%26%36%
46%35%51%69%
----
26%32%17%23%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
KPL
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,773.4₹425150 Cr38.778.2958.23₹11479 Cr
10,037.5₹266265 Cr91.0334.04128.41₹2568 Cr
4,738.5₹176301 Cr8314.04106.21₹2163 Cr
2,323.8₹125352 Cr93.568.1733.94₹889 Cr
1,188.1₹123591 Cr27.399.4262.53₹5040 Cr
1,374₹114351 Cr40.8411.0859.2₹4196 Cr
1,402₹112474 Cr38.8210.8652.6₹3879 Cr
2,537.9₹102315 Cr45.6217.2376.26₹1913 Cr
1,705₹97757 Cr26.3317.9596.84₹3505 Cr
2,008.6₹92007 Cr16.6430.95154.35₹5333 Cr
3,765₹3766 Cr46.4724.797.43₹67 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021
₹162 Cr₹157 Cr₹123 Cr₹111 Cr₹111 Cr₹116 Cr₹84 Cr₹90 Cr₹80 Cr₹92 Cr₹78 Cr₹70 Cr₹67 Cr₹69 Cr₹56 Cr₹56 Cr₹70 Cr₹64 Cr₹88 Cr₹184 Cr₹120 Cr
₹62 L₹1 Cr₹53 L₹90 L₹38 L₹77 L₹66 L₹22 L₹28 L₹58 L₹62 L₹23 L₹40 L₹1 Cr₹35 L₹1 Cr₹38 L₹2 Cr₹84 L₹12 L₹96 L
₹163 Cr₹158 Cr₹124 Cr₹112 Cr₹112 Cr₹116 Cr₹85 Cr₹90 Cr₹80 Cr₹93 Cr₹79 Cr₹70 Cr₹68 Cr₹70 Cr₹57 Cr₹57 Cr₹71 Cr₹66 Cr₹89 Cr₹184 Cr₹121 Cr
₹126 Cr₹124 Cr₹98 Cr₹91 Cr₹92 Cr₹95 Cr₹71 Cr₹75 Cr₹67 Cr₹76 Cr₹66 Cr₹59 Cr₹58 Cr₹62 Cr₹45 Cr₹44 Cr₹55 Cr₹51 Cr₹67 Cr₹103 Cr₹75 Cr
₹42 Cr₹40 Cr₹30 Cr₹26 Cr₹25 Cr₹27 Cr₹18 Cr₹20 Cr₹18 Cr₹21 Cr₹17 Cr₹15 Cr₹14 Cr₹13 Cr₹15 Cr₹17 Cr₹18 Cr₹18 Cr₹25 Cr₹84 Cr₹48 Cr
₹3 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹3 Cr₹2 Cr₹3 Cr₹3 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹50 L₹71 L₹68 L
₹34 Cr₹32 Cr₹22 Cr₹18 Cr₹17 Cr₹19 Cr₹11 Cr₹13 Cr₹11 Cr₹6 Cr₹10 Cr₹8 Cr₹7 Cr-₹10 Cr₹10 Cr₹12 Cr₹14 Cr₹14 Cr₹22 Cr₹80 Cr₹46 Cr
₹26 Cr₹25 Cr₹16 Cr₹14 Cr₹12 Cr₹14 Cr₹9 Cr₹8 Cr₹8 Cr₹4 Cr₹8 Cr₹6 Cr₹5 Cr-₹7 Cr₹7 Cr₹9 Cr₹11 Cr₹10 Cr₹16 Cr₹60 Cr₹34 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Revaluation reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
—————————————
₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹10 Cr₹5 Cr₹5 Cr₹4 Cr₹4 Cr
₹321 Cr₹254 Cr₹214 Cr₹190 Cr₹171 Cr₹51 Cr₹36 Cr₹27 Cr₹19 Cr₹20 Cr₹17 Cr₹15 Cr₹13 Cr
₹320 Cr₹253 Cr₹213 Cr₹189 Cr₹170 Cr₹50 Cr₹35 Cr₹26 Cr₹19 Cr₹20 Cr₹16 Cr₹14 Cr₹13 Cr
₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L₹80 L
₹332 Cr₹264 Cr₹224 Cr₹201 Cr₹181 Cr₹61 Cr₹46 Cr₹37 Cr₹30 Cr₹26 Cr₹22 Cr₹19 Cr₹18 Cr
-₹2 Cr-₹2 Cr-₹2 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹1 Cr-₹98 L-₹99 L-₹50 L-₹41 L-₹14 L-₹3 L
₹29 Cr₹15 Cr₹20 Cr₹27 Cr₹20 Cr₹16 Cr₹8 Cr₹7 Cr₹3 Cr₹3 Cr₹2 Cr₹30 L₹54 L
₹0₹0₹0₹12 L₹70 L₹2 Cr₹2 Cr₹58 L₹2 Cr₹67 L₹35 L₹50 L₹87 L
-₹3 Cr-₹2 Cr-₹3 L₹41 L₹27 L-₹4 L-₹20 L₹12 L₹21 L₹40 L₹45 L₹4 L₹60 L
₹6 Cr₹0₹0₹0₹0₹9 Cr₹9 Cr₹0₹0₹0₹0₹0₹0
₹1 Cr₹25 L₹22 L₹90 L₹75 L₹68 L₹62 L₹52 L₹55 L₹54 L₹17 L₹0₹10 L
₹34 Cr₹14 Cr₹20 Cr₹29 Cr₹21 Cr₹28 Cr₹20 Cr₹8 Cr₹5 Cr₹4 Cr₹3 Cr₹83 L₹2 Cr
—————————————
₹102 Cr₹56 Cr₹44 Cr₹35 Cr₹35 Cr₹26 Cr₹23 Cr₹17 Cr₹22 Cr₹13 Cr₹10 Cr₹4 Cr₹7 Cr
₹30 Cr₹24 Cr₹35 Cr₹33 Cr₹41 Cr₹30 Cr₹21 Cr₹22 Cr₹16 Cr₹11 Cr₹6 Cr₹6 Cr₹4 Cr
₹85 Cr₹83 Cr₹66 Cr₹51 Cr₹23 Cr₹16 Cr₹21 Cr₹19 Cr₹21 Cr₹15 Cr₹10 Cr₹7 Cr₹4 Cr
₹9 Cr₹6 Cr₹7 Cr₹6 Cr₹41 Cr₹6 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹58 L₹2 L
₹226 Cr₹170 Cr₹152 Cr₹126 Cr₹139 Cr₹78 Cr₹68 Cr₹61 Cr₹62 Cr₹42 Cr₹27 Cr₹17 Cr₹15 Cr
₹590 Cr₹446 Cr₹394 Cr₹354 Cr₹341 Cr₹166 Cr₹132 Cr₹105 Cr₹96 Cr₹71 Cr₹51 Cr₹37 Cr₹35 Cr
₹37 Cr₹37 Cr₹35 L₹51 L₹5 L₹59 L₹1 Cr₹5 Cr₹0₹0₹0₹0₹0
₹130 Cr₹112 Cr₹98 Cr₹90 Cr₹54 Cr₹41 Cr₹35 Cr₹29 Cr₹26 Cr₹19 Cr₹13 Cr₹8 Cr₹6 Cr
—————————————
₹261 Cr₹232 Cr₹207 Cr₹170 Cr₹128 Cr₹82 Cr₹63 Cr₹41 Cr₹32 Cr₹28 Cr₹23 Cr₹23 Cr₹21 Cr
₹106 Cr₹86 Cr₹68 Cr₹50 Cr₹36 Cr₹26 Cr₹20 Cr₹19 Cr₹15 Cr₹13 Cr₹10 Cr₹10 Cr₹9 Cr
₹156 Cr₹146 Cr₹139 Cr₹120 Cr₹92 Cr₹57 Cr₹43 Cr₹23 Cr₹16 Cr₹16 Cr₹13 Cr₹13 Cr₹13 Cr
₹17 Cr₹0₹0₹14 Cr₹12 Cr₹3 Cr₹0₹6 Cr₹4 Cr₹1 Cr₹0₹0₹0
₹0₹0₹0₹0₹0₹73 L₹65 L₹79 L₹63 L₹62 L₹3 L₹3 L₹14 L
₹0₹0₹0₹0₹0₹73 L₹65 L₹79 L₹63 L₹62 L₹3 L₹3 L₹14 L
₹11 Cr₹16 Cr₹12 Cr₹11 Cr₹8 Cr₹17 L₹12 L₹12 L₹12 L₹12 L₹12 L₹10 L₹0
₹0₹0₹0₹93 L₹78 L₹0₹0₹0₹0₹0₹0₹0₹0
₹184 Cr₹162 Cr₹151 Cr₹146 Cr₹113 Cr₹60 Cr₹43 Cr₹30 Cr₹21 Cr₹18 Cr₹13 Cr₹13 Cr₹13 Cr
—————————————
₹0₹0₹0₹0₹0₹4 Cr₹3 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹97 L₹50 L
₹78 Cr₹83 Cr₹78 Cr₹86 Cr₹53 Cr₹17 Cr₹22 Cr₹11 Cr₹15 Cr₹14 Cr₹10 Cr₹6 Cr₹7 Cr
₹280 Cr₹154 Cr₹114 Cr₹72 Cr₹69 Cr₹36 Cr₹30 Cr₹38 Cr₹37 Cr₹23 Cr₹18 Cr₹9 Cr₹7 Cr
₹4 Cr₹15 Cr₹6 Cr₹7 Cr₹13 Cr₹6 Cr₹2 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹90 L
₹30 L₹0₹7 Cr₹0₹0₹9 L₹12 L₹6 L₹12 L₹5 L₹6 L₹3 L₹7 L
₹43 Cr₹31 Cr₹37 Cr₹42 Cr₹92 Cr₹42 Cr₹31 Cr₹20 Cr₹16 Cr₹11 Cr₹6 Cr₹7 Cr₹7 Cr
₹406 Cr₹284 Cr₹243 Cr₹207 Cr₹228 Cr₹106 Cr₹89 Cr₹75 Cr₹75 Cr₹53 Cr₹38 Cr₹24 Cr₹22 Cr
₹180 Cr₹114 Cr₹91 Cr₹81 Cr₹88 Cr₹28 Cr₹21 Cr₹15 Cr₹13 Cr₹11 Cr₹12 Cr₹7 Cr₹7 Cr
₹0₹0₹0₹0₹0₹0₹0₹3 L₹7 L₹10 L₹14 L₹0₹0
₹590 Cr₹446 Cr₹394 Cr₹354 Cr₹341 Cr₹166 Cr₹132 Cr₹105 Cr₹96 Cr₹71 Cr₹51 Cr₹37 Cr₹35 Cr
₹319₹254₹215₹192₹174₹58₹44₹35₹28₹48₹42₹42₹39
₹319₹254₹215₹192₹174₹58₹44₹35₹28₹24₹21₹21₹19

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015Mar 2014
₹89 Cr₹54 Cr₹31 Cr₹26 Cr₹162 Cr₹21 Cr₹11 Cr₹11 Cr₹7 Cr₹6 Cr₹2 Cr₹1 Cr₹2 Cr
₹31 Cr₹28 Cr₹37 Cr₹21 Cr₹14 Cr₹9 Cr₹7 Cr₹5 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹2 Cr
-₹83 Cr-₹14 Cr-₹23 Cr₹1 Cr-₹73 Cr₹3 Cr-₹9 Cr₹89 L-₹9 Cr-₹4 Cr-₹7 Cr-₹2 Cr-₹4 Cr
₹37 Cr₹69 Cr₹44 Cr₹48 Cr₹102 Cr₹33 Cr₹9 Cr₹17 Cr₹2 Cr₹7 Cr-₹2 Cr₹2 Cr-₹28 L
₹17 Cr₹53 Cr₹43 Cr₹41 Cr₹61 Cr₹27 Cr₹6 Cr₹14 Cr-₹57 L₹4 Cr-₹3 Cr₹1 Cr-₹70 L
-₹35 Cr-₹29 Cr-₹26 Cr-₹48 Cr-₹63 Cr-₹23 Cr-₹18 Cr-₹12 Cr-₹6 Cr-₹7 Cr-₹2 Cr-₹1 Cr-₹3 Cr
₹7 Cr-₹14 Cr-₹17 Cr₹99 L₹6 Cr₹77 L₹12 Cr-₹2 Cr₹5 Cr₹5 Cr₹6 Cr₹99 L₹3 Cr
-₹11 Cr₹10 Cr-₹81 L-₹6 Cr₹3 Cr₹4 Cr₹14 L-₹21 L-₹1 Cr₹2 Cr₹31 L₹79 L-₹1 Cr
₹12 Cr₹2 Cr₹3 Cr₹9 Cr₹6 Cr₹2 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹25 L₹2 Cr
₹74 L₹12 Cr₹2 Cr₹3 Cr₹9 Cr₹6 Cr₹2 Cr₹1 Cr₹2 Cr₹3 Cr₹1 Cr₹1 Cr₹90 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)3,679.00
Volume (₹)36,031.00
High (₹)3,783.00
Upper Circuit4,357.00
Low (₹)3,583.10
Lower Circuit2,904.80
Prev Close3,630.90
52W High (₹)3,949.00
Price3,765.00
52W Low (₹)1,561.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)3765.99 Cr
Div. Yield (%)0.00
PE Ratio46.47
Debt to Equity0.39
Price to Book4.10
Book Value318.80
EPS (TTM)78.11
Face Value10.00
ROE (%)22.67

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
KPLNSE
LTP
1W Low
1W High
Market cap (₹)
1773.4-4.3 (-0.24%)
1722
1810.40
4,25,150Cr
10037.5+257.5 (2.63%)
9863
10067
2,66,265Cr
4738.5+125.1 (2.71%)
4553
4738.50
1,76,301Cr
2323.8-81.7 (-3.40%)
2252.40
2441.90
1,25,352Cr
1188.1-57.4 (-4.61%)
1182.40
1266.60
1,23,591Cr
1374+22 (1.63%)
1336.70
1376.70
1,14,351Cr
1402+23.1 (1.68%)
1364.60
1402
1,12,474Cr
2537.9+45.1 (1.81%)
2457.90
2540
1,02,315Cr
1705+23.6 (1.40%)
1656.20
1724.60
97,757Cr
2008.6-2.4 (-0.12%)
1988.90
2062.10
92,007Cr
3765+289.7 (8.34%)
3401
3783
3,766Cr

Kwality Pharmaceuticals Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹41.64Cr; with other income of ₹62.3Lakh, profit before interest and tax came to ₹36.65Cr. Interest expense was ₹2.66Cr; PBT before exceptional items stood at ₹33.99Cr. Cost mix (full year): raw materials ₹179.16Cr; employee cost ₹51.1Cr; depreciation ₹5Cr; other expenses ₹121.33Cr. Basis: consolidated annual results.

Kwality Pharmaceuticals Ltd Quaterly Results Key Takeaways

Kwality Pharmaceuticals Ltd reported ₹162.35Cr total income from operations in Jun 2026, softer than ₹157.11Cr in Mar 2026 but higher than ₹111.48Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹41.64Cr; with other income of ₹62.3Lakh, profit before interest and tax came to ₹36.65Cr. Interest expense was ₹2.66Cr, taking profit before tax to ₹33.99Cr. After tax of ₹8.37Cr, profit after tax stood at ₹25.62Cr (vs ₹25.31Cr in Mar 2026 and ₹11.92Cr in Jun 2025).